Development and optimization of baicalin-loaded solid lipid nanoparticles prepared by coacervation method using central composite design

European Journal of Pharmaceutical Sciences

Volumn 47, Issue 2, 2012, Pages 497-505

  Hao, Jifu ^a,b   Wang, Fugang ^b   Wang, Xiaodan ^b   Zhang, Dianrui ^a   Bi, Yanping ^b   Gao, Yunsheng ^b   Zhao, Xuemei ^b   Zhang, Qiang ^c  

^a SHANDONG UNIVERSITY   (China)

^b TAISHAN MEDICAL UNIVERSITY   (China)

^c PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Baicalin; Central composite design; Coacervation method; Solid lipid nanoparticle

Indexed keywords

BAICALIN; FATTY ACID; NONIONIC SURFACTANT; SODIUM; SODIUM CHLORIDE; SOLID LIPID NANOPARTICLE; STEARIC ACID;

ANIMAL EXPERIMENT; ARTICLE; CENTRAL COMPOSITE DESIGN; CHEMICAL COMPOSITION; COACERVATION; COMPOSITE MATERIAL; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; MORPHOLOGY; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RAT; SCANNING ELECTRON MICROSCOPY;

ADMINISTRATION, ORAL; ANIMALS; BIOLOGICAL AVAILABILITY; CALORIMETRY, DIFFERENTIAL SCANNING; DRUG CARRIERS; DRUG COMPOUNDING; FLAVONOIDS; MICROSCOPY, ELECTRON, SCANNING; NANOPARTICLES; PARTICLE SIZE; RATS; RATS, WISTAR; STEARIC ACIDS;

EID: 84864513259     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2012.07.006     Document Type: Article

References (31)

1. T. Akao, K. Kawabata, E. Yanagisawa, K. Ishihara, Y. Mizuhara, Y. Wakui, Y. Sakashita, and K. Kobashi Balicalin, the predominant flavone glucuronide of Scutellariae Radix, is absorbed from the rat gastrointestinal tract as the aglycone and restored to its original form J. Pharm. Pharmacol. 52 2000 1563 1568
2. A.A. Attama SLN, NLC, LDC: state of the art in drug and active delivery Recent Pat. Drug Deliv. Formul. 5 2011 178 187
3. L. Battaglia, M. Gallarate, R. Cavalli, and M. Trotta Solid lipid nanoparticles produced through a coacervation method J. Microencapsul. 27 2010 78 85
4. L. Battaglia, L. Serpe, E. Muntoni, G. Zara, M. Trotta, and M. Gallarate Methotrexate-loaded SLNs prepared by coacervation technique: in vitro cytotoxicity and in vivo pharmacokinetics and biodistribution Nanomedicine (London) 6 2011 1561 1573
5. M.A. Bianco, M. Gallarate, M. Trotta, and L. Battaglia Amphotericin B loaded SLN prepared with the coacervation technique J. Drug Deliv. Sci. Technol. 20 2010 187 191
6. F. Corrias, and F. Lai New methods for lipid nanoparticles preparation Recent Pat Drug Deliv. Formul. 5 2011 201 213
7. Y. El-Malah, S. Nazzal, and N.M. Khanfar D-optimal mixture design: optimization of ternary matrix blends for controlled zero-order drug release from oral dosage forms Drug Dev. Ind. Pharm. 32 2006 1207 1218
8. A.T. Florence Issues in oral nanoparticle drug carrier uptake and targeting J. Drug Target 12 2004 65 70
9. M. Gallarate, M. Trotta, L. Battaglia, and D. Chirio Cisplatin-loaded SLN produced by coacervation technique J. Drug Deliv. Sci. Technol. 20 2010 343 347
10. E.H. Gokce, G. Sandri, M.C. Bonferoni, S. Rossi, F. Ferrari, T. Güneri, and C. Caramella Cyclosporine A loaded SLNs: evaluation of cellular uptake and corneal cytotoxicity Int. J. Pharm. 364 2008 76 86
11. E. Gonzalez-Mira, M. Egea, E. Souto, A. Calpena, and M. García Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery Nanotechnology 22 2011 045101
12. H. Harde, M. Das, and S. Jain Solid lipid nanoparticles: an oral bioavailability enhancer vehicle Expert Opin. Drug Deliv. 2011 1 18
13. L. Jia, H. Wong, C. Cerna, and S.D. Weitman Effect of nanonization on absorption of 301029: ex vivo and in vivo pharmacokinetic correlations determined by liquid chromatography/mass spectrometry Pharm. Res. 19 2002 1091 1096
14. X. Jin, Y. Zhang, L. Xiao, and Z. Zhao Optimization of extended zero-order release gliclazide tablets using D-optimal mixture design Yakugaku Zasshi 128 2008 1475 1483
15. S. Kobierski, K. Ofori-Kwakye, R. Muller, and C. Keck Resveratrol nanosuspensions for dermal application production, characterization, and physical stability Die Pharma. 64 2009 741 747
16. C.H. Liu, and C.T. Wu Optimization of nanostructured lipid carriers for lutein delivery Colloids Surf. Physicochem. Eng. Aspects 353 2010 149 156
17. C.H. Liu, C.T. Wu, and J.Y. Fang Characterization and formulation optimization of solid lipid nanoparticles in vitamin K1 delivery Drug Dev. Ind. Pharm. 36 2010 751 761
18. Z. Liu, X. Zhang, H. Wu, J. Li, L. Shu, R. Liu, L. Li, and N. Li Preparation and evaluation of solid lipid nanoparticles of baicalin for ocular drug delivery system in vitro and in vivo Drug Dev. Ind. Pharm. 2010 1 8
19. Q. Lv, A. Yu, Y. Xi, H. Li, Z. Song, J. Cui, F. Cao, and G. Zhai Development and evaluation of penciclovir-loaded solid lipid nanoparticles for topical delivery Int. J. Pharm. 372 2009 191 198
20. R.H. Muller, K. Maeder, and S. Gohla Solid lipid nanoparticles (SLN) for controlled drug delivery: a review of the state of the art Eur. J. Pharm. Biopharm. 50 2000 161 177
21. Z. Rahman, A.S. Zidan, M.J. Habib, and M.A. Khan Understanding the quality of protein loaded PLGA nanoparticles variability by Plackett-Burman design Int. J. Pharm. 389 2010 186 194
22. Z. Rahman, A.S. Zidan, and M.A. Khan Non-destructive methods of characterization of risperidone solid lipid nanoparticles Eur. J. Pharm. Biopharm. 76 2010 127 137
23. Y.C. Shen, W.F. Chiou, Y.C. Chou, and C.F. Chen Mechanisms in mediating the anti-inflammatory effects of baicalin and baicalein in human leukocytes Eur. J. Pharmacol. 465 2003 171 181
24. J. Sun, and S. Simon The melting behavior of aluminum nanoparticles Thermochim. Acta 463 2007 32 40
25. P.L. Tsai, and T.H. Tsai Pharmacokinetics of baicalin in rats and its interactions with cyclosporin A, quinidine and SKF-525A: a microdialysis study Planta Med. 70 2004 1069 1074
26. J. Varshosaz, S. Ghaffari, M.R. Khoshayand, F. Atyabi, S. Azarmi, and F. Kobarfard Development and optimization of solid lipid nanoparticles of amikacin by central composite design J. Liposome Res. 20 2010 97 104
27. J. Varshosaz, M. Tabbakhian, and M.Y. Mohammadi Formulation and optimization of solid lipid nanoparticles of buspirone HCl for enhancement of its oral bioavailability J. Liposome Res. 20 2010 286 296
28. S. Verma, Y. Lan, R. Gokhale, and D.J. Burgess Quality by design approach to understand the process of nanosuspension preparation Int. J. Pharm. 377 2009 185 198
29. J. Xing, X. Chen, and D. Zhong Absorption and enterohepatic circulation of baicalin in rats Life Sci. 78 2005 140 146
30. J. Zhang, Y. Fan, and E. Smith Experimental design for the optimization of lipid nanoparticles J. Pharm. Sci. 98 2009 1813 1819
31. J. Zhang, H. Lv, K. Jiang, and Y. Gao Enhanced bioavailability after oral and pulmonary administration of baicalein nanocrystal Int. J. Pharm. 420 2011 180 188